Table of Contents Author Guidelines Submit a Manuscript
Journal of Osteoporosis
Volume 2013, Article ID 231289, 7 pages
http://dx.doi.org/10.1155/2013/231289
Research Article

Decayed, Missing, and Filled Teeth Index and Periodontal Health in Osteoporotic Patients Affected by BRONJ: An Observational Study

1Department of Biomedical Sciences and Specialist Medical-Surgical Dentistry, University of Messina, Via Consolare Valeria, 98100 Messina, Italy
2Human Pathology Department, Dental School, University of Messina, Via Consolare Valeria, 98100 Messina, Italy

Received 22 September 2013; Revised 6 November 2013; Accepted 7 November 2013

Academic Editor: Manuel Diaz Curiel

Copyright © 2013 Giacomo Oteri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. NIH Consensus Statement, Osteoporosis Prevention, Diagnosis and Therapy, vol. 17, NIH Consensus Statement, Washington, DC, USA, 2000.
  2. J. Compston, “Action Plan for the prevention of osteoporotic fractures in the European Community,” Osteoporosis International, vol. 15, no. 4, pp. 259–262, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. R. S. Stafford, R. L. Drieling, and A. L. Hersh, “National trends in osteoporosis visits and osteoporosis treatment, 1988–2003,” Archives of Internal Medicine, vol. 164, no. 14, pp. 1525–1530, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Felsenberg and S. Boonen, “The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management,” Clinical Therapeutics, vol. 27, no. 1, pp. 1–11, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. S. L. Ruggiero, B. Mehrotra, T. J. Rosenberg, and S. L. Engroff, “Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases,” Journal of Oral and Maxillofacial Surgery, vol. 62, no. 5, pp. 527–534, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. R. G. Russell, “Bisphosphonates: the first 40 years,” Bone, vol. 49, no. 1, pp. 2–19, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. G. A. Rodan and A. A. Reszka, “Bisphosphonate mechanism of action,” Current Molecular Medicine, vol. 2, no. 6, pp. 571–577, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. R. G. Russell, “Bisphosphonates: mode of action and pharmacology,” Pediatrics, vol. 119, supplement 2, pp. S150–S162, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. S. L. Ruggiero, T. B. Dodson, L. A. Assael, R. Landesberg, R. E. Marx, and B. Mehrotra, “American association of oral and Maxillofacial surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update,” Journal of Oral and Maxillofacial Surgery, vol. 67, no. 5, pp. 2–12, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Otto, M. H. Abu-Id, S. Fedele et al., “Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence-a multi-centre study,” Journal of Cranio-Maxillofacial Surgery, vol. 39, no. 4, pp. 272–277, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Becker, L. Levin, T. Shochat, and S. Einy, “How much does the DMFT index underestimate the need for restorative care?” Journal of Dental Education, vol. 71, no. 5, pp. 677–681, 2007. View at Google Scholar · View at Scopus
  12. P. Eickholz, “Clinical periodontal diagnosis: probing pocket depth, vertical attachment level and bleeding on probing,” Perio, vol. 1, no. 1, pp. 75–80, 2004. View at Google Scholar
  13. J. G. Neely, J. M. Hartman, J. W. Forsen Jr., and M. S. Wallace, “Tutorials in clinical research: VII. Understanding comparative statistics (contrast)-part B: application of t-test, Mann-Whitney U, and chi-square,” Laryngoscope, vol. 113, no. 10, pp. 1719–1725, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. D. L. Brunello and M. N. Mandikos, “Construction faults, age, gender, and relative medical health: factors associated with complaints in complete denture patients,” Journal of Prosthetic Dentistry, vol. 79, no. 5, pp. 545–554, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. M. E. Sarasquete, R. García-Sanz, L. Marín et al., “Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytoehrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis,” Blood, vol. 112, no. 7, pp. 2709–2712, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Coskun Benlidayi and R. Guzel, “Oral bisphosphonate related osteonecrosis of the jaw: a challenging adverse effect,” ISRN Rheumatology, vol. 2013, Article ID 215034, 6 pages, 2013. View at Publisher · View at Google Scholar
  17. P. Sambrook, I. Olver, and A. N. Goss, “Bisphosphonates and osteonecrosis of the jaw. Position statement on behalf of the Australian and New Zealand Bone Mineral Society, Osteoporosis Australia, Medical Oncology Group of Australia and the Australian Dental Society,” Australian Family Physician, vol. 35, pp. 801–803, 2006. View at Google Scholar
  18. E. Vairaktaris, S. Vassiliou, D. Avgoustidis, P. Stathopoulos, T. Toyoshima, and C. Yapijakis, “Bisphosphonate-induced avascular osteonecrosis of the Mandible associated with a common thrombophilic mutation in the prothrombin gene,” Journal of Oral and Maxillofacial Surgery, vol. 67, no. 9, pp. 2009–2012, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Manfredi, E. Merigo, R. Guidotti, M. Meleti, and P. Vescovi, “Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis,” International Journal of Oral and Maxillofacial Surgery, vol. 40, no. 3, pp. 277–284, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Favia, G. P. Pilolli, and E. Maiorano, “Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients,” Journal of Rheumatology, vol. 36, no. 12, pp. 2780–2787, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Gasparini, G. Saponaro, F. Di Nardo et al., “Clinical experience with spiramycin in bisphosphonate-associated osteonecrosis of the jaw,” International Journal of Immunopathology and Pharmacology, vol. 23, no. 2, pp. 619–626, 2010. View at Google Scholar · View at Scopus
  22. D. Carmagnola, S. Celestino, and S. Abati, “Dental and periodontal history of oncologic patients on parenteral bisphosphonates with or without osteonecrosis of the jaws: a pilot study,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 106, no. 6, pp. e10–e15, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. S.-B. Woo, J. W. Hellstein, and J. R. Kalmar, “Systematic review: bisphosphonates and osteonecrosis of the jaws,” Annals of Internal Medicine, vol. 144, no. 10, pp. 753–761, 2006. View at Google Scholar · View at Scopus
  24. P. G. Arduino, E. Menegatti, M. Scoletta et al., “Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws,” Journal of Oral Pathology and Medicine, vol. 40, no. 6, pp. 510–515, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. S. E. Pichardo and J. P. van Merkesteyn, “Bisphosphonate related osteonecrosis of the jaws: spontaneous or dental origin?” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, vol. 116, no. 3, pp. 287–292, 2013. View at Publisher · View at Google Scholar
  26. A. Dentino, S. Lee, J. Mailhot, and A. F. Hefti, “Principles of periodontology,” Periodontol 2000, vol. 61, no. 1, pp. 16–53, 2013. View at Google Scholar
  27. D. Black, D. Bauer, A. Schwartz, S. Cummings, and C. Rosen, “Continuing bisphosphonate treatment for osteoporosis—for whom and for how long?” The New England Journal of Medicine, vol. 366, no. 22, pp. 2051–2053, 2012. View at Publisher · View at Google Scholar
  28. M. Cicciù, A. S. Herford, G. Juodžbalys, and E. Stoffella, “Recombinant human bone morphogenetic protein type 2 application for a possible treatment of bisphosphonates-related osteonecrosis of the jaw,” Journal of Craniofacial Surgery, vol. 23, no. 3, pp. 784–788, 2012. View at Publisher · View at Google Scholar · View at Scopus